Freedom of Information request on the adverse reactions reported via the yellow card scheme (FOI 22/497)
Published 31 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-28-february-2022/freedom-of-information-request-on-the-adverse-reactions-reported-via-the-yellow-card-scheme-foi-22497
FOI 22/497
28th February 2022
Dear
Thank you for your email dated 22nd February 2022. The MHRA publishes interactive Drug Analysis Profiles (iDAPs) for all licensed drugs for which we have received reports of suspected adverse reactions in the UK. Therefore the data you have requested is publicly available and can be accessed using the link below:
https://yellowcard.mhra.gov.uk/idaps
Should you require further assistance, please do not hesitate to contact us.
Kind regards,
FOI Team